Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $7.6 Million - $9.44 Million
-32,380 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $44,970 - $55,808
-200 Reduced 0.61%
32,380 $8.94 Million
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $10.9 Million - $14.2 Million
-60,620 Reduced 65.04%
32,580 $7.48 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $13.6 Million - $17.5 Million
82,500 Added 771.03%
93,200 $17.4 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $9.89 Million - $13.1 Million
-75,808 Reduced 87.63%
10,700 $1.81 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $2.35 Million - $2.72 Million
-16,100 Reduced 15.69%
86,508 $12.8 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $3.11 Million - $3.74 Million
22,808 Added 28.58%
102,608 $16.8 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $7.21 Million - $8.93 Million
60,600 Added 315.63%
79,800 $11.1 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $2.05 Million - $2.54 Million
19,200 New
19,200 $2.52 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $1.38 Million - $1.51 Million
-12,960 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $1.1 Million - $1.29 Million
-9,973 Reduced 43.49%
12,960 $1.44 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $666,524 - $784,547
-5,988 Reduced 20.7%
22,933 $2.98 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $1.29 Million - $1.61 Million
15,000 Added 107.75%
28,921 $3.1 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $1.97 Million - $2.26 Million
-26,057 Reduced 65.18%
13,921 $1.19 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $2.97 Million - $3.5 Million
39,978 New
39,978 $3.09 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.